Purification, crystallization and preliminary X-ray analysis of Enterococcus faecium aminoglycoside-2''-phosphotransferase-Ib [APH(2'')-Ib

Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
Rupa WalanjClyde A Smith

Abstract

Bacterial resistance to the aminoglycoside antibiotics is primarily the result of deactivation of the drugs. Three families of enzymes are responsible for this activity, with one such family being the aminoglycoside phosphotransferases (APHs). The gene encoding one of these enzymes, APH(2'')-Ib, has been cloned and the protein (comprising 299 amino-acid residues) expressed in Escherichia coli, purified and crystallized in the presence of 16%(w/v) PEG 3350 and gentamicin. The crystals belong to the monoclinic space group P2(1), with approximate unit-cell parameters a = 79.7, b = 58.8, c = 81.4 A, beta = 98.4 degrees, and preliminary X-ray diffraction analysis is consistent with the presence of two molecules in the asymmetric unit. Synchrotron diffraction data to approximately 2.65 A resolution were collected from a native APH(2'')-Ib crystal at beamline BL9-2 at SSRL (Stanford, CA, USA). Selenium-substituted crystals have also been produced and structure determination is proceeding.

References

Apr 28, 1968·Journal of Molecular Biology·B W Matthews
Dec 1, 1994·European Journal of Biochemistry·R Karimi, M Ehrenberg
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·S J KaoJ W Chow
May 15, 2002·The EMBO Journal·Desiree H Fong, Albert M Berghuis
Dec 5, 2002·Current Drug Targets. Infectious Disorders·Clyde A Smith, Edward N Baker
Jul 15, 2003·Clinical Microbiology Reviews·Sergei B Vakulenko, Shahriar Mobashery

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
Laura J ByrnesClyde A Smith
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
Marta TothClyde A Smith
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
Marta TothClyde A Smith
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
Marta TothClyde A Smith
© 2021 Meta ULC. All rights reserved